Description
The study shows both sAPPα (non-amyloidogenic) and sAPPβ (amyloidogenic) are elevated in AD plasma, which is unexpected since these represent competing cleavage pathways. The underlying mechanism explaining this simultaneous increase remains unclear and could reveal new therapeutic targets.
Gap type: unexplained_observation Source paper: Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer’s disease. (2012, Journal of neuroscience research, PMID:22987781)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:35.688951+00:00”, “resolution_summary”: “Resolved by hypothesis h-a6e77292: SGMS1-Driven Sphingomyelin Accumulation Impairs BACE1 Lysosomal Degradation via Autophagosome-Lysosome Fusion Dysfunction. Supporting evidence includes debate sess_SDA-2026-04-15-gap-pubmed-20260411-093843-0a9326c2_20260416-032731.”, “match_counts”: {“hypothesis_matches”: 3, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-a6e77292”, “title”: “SGMS1-Driven Sphingomyelin Accumulation Impairs BACE1 Lysosomal Degradation via Autophagosome-Lysosome Fusion Dysfunction”, “score”: 0.239, “reason”: “22 token overlaps; entity overlap: bace1”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-083737-59771b32”, “target_gene”: “SGMS1, BECN1”, “target_pathway”: “Autophagy / beclin-1”, “disease”: “neurodegeneration”, “composite_score”: 0.734, “confidence_score”: 0.72, “status”: “promoted”, “pubmed_evidence_ids”: [“23827971”, “23977395”, “28028177”, “30243987”, “N/A”]}, {“id”: “hyp-SDA-2026-04-12-20260411-082446-2c1c9e2d-2”, “title”: “Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbates Amyloid Pathology”, “score”: 0.237, “reason”: “23 token overlaps; entity overlap: bace1”, “analysis_id”: “SDA-2026-04-12-20260411-082446-2c1c9e2d”, “target_gene”: “CHRNA7 (α7 nicotinic receptor), BACE1”, “target_pathway”: “Cholinergic signaling pathway”, “disease”: null, “composite_score”: 0.785, “confidence_score”: 0.55, “status”: “debated”, “pubmed_evidence_ids”: [“20600777”, “20943921”, “21921156”, “23201341”, “23324234”]}, {“id”: “h-73124693”, “title”: “BACE1/NRG1 Axis Dysfunction Drives Excitatory/Inhibitory Imbalance via PV Interneuron Hypofunction”, “score”: 0.223, “reason”: “19 token overlaps; entity overlap: bace1”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-093843-0a9326c2”, “target_gene”: “NRG1/ERBB4”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.743, “confidence_score”: 0.72, “status”: “promoted”, “pubmed_evidence_ids”: [“16990514”, “17099708”, “20393464”, “20943921”, “21209185”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-093843-0a9326c2_20260416-032731”, “title”: “The abstract identifies BACE1 as an attractive drug target but doesn’t address its normal physiological roles. Understanding these functions is critical to predict potential adverse effects of BACE1 inhibitors in therapeutic development.\n\nGap type: open_question\nSource paper: BACE1: the beta-secretase enzyme in Alzheimer’s disease. (2004, Journal of molecular neuroscience : MN, PMID:15126696)”, “score”: 0.521, “reason”: “9 token overlaps; entity overlap: bace1, pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-093843-0a9326c2”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1_task_9aae8fc5”, “title”: “The abstract identifies APOE4 association with increased TDP-43 pathology but the mechanistic link is unexplained. This connection could reveal novel therapeutic targets since APOE4 is the strongest genetic risk factor for AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.457, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-181258-df5eee45”, “title”: “The study shows that OB microglia phagocytose LC axons before amyloid plaque formation, but the molecular signals that mark these axons for destruction are unknown. Understanding this mechanism could reveal early therapeutic targets to prevent noradrenergic denervation.\n\nGap type: unexplained_observation\nSource paper: Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease. (2025, Nature communications, PMID:40781079)”, “score”: 0.444, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-181258-df5eee45”, “quality_score”: 0.7, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-171918-9936a995”, “title”: “The study demonstrates that high-neural glioblastoma cells form synapses with neurons both in vitro and in vivo, but the underlying molecular mechanisms are not explained. Understanding these mechanisms could reveal novel therapeutic targets to disrupt this tumor-promoting interaction.\n\nGap type: unexplained_observation\nSource paper: A prognostic neural epigenetic signature in high-grade glioma. (None, None, PMID:38760585)”, “score”: 0.407, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-171918-9936a995”, “quality_score”: 0.62, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a_task_73907230”, “title”: “The study shows P2RY12 regulates VSMC foam cell formation but doesn’t explain what controls P2RY12 expression or activation in VSMCs during disease progression. Understanding these upstream regulators could reveal new therapeutic targets for vascular neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. (2021, Autophagy, PMID:32160082)”, “score”: 0.402, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a”, “quality_score”: 0.661, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}